NCT05116189 2026-03-09KEYNOTE-B96Merck Sharp & Dohme LLCPhase 3 Active not recruiting643 enrolled 17 charts 3 FDA
NCT03740165 2025-10-22KEYLYNK-001Merck Sharp & Dohme LLCPhase 3 Active not recruiting1,367 enrolled 29 charts
NCT00753740 2020-06-12Efficacy Study of Maintenance IT-101 Therapy for Ovarian Cancer Patients.Lumos PharmaPhase 2 Withdrawn